FDA Webview
X
about-us-banner

Articles

Home /Articles / FDA Federal Register Notices

Panel to Discuss Boehringer NDA for COPD

06/26/2014

OMB OKs Info on Importer’s Entry Notice

06/26/2014

Federal Register Notice: FDA’s collection of information entitled “Importer's Entry Notice” has been approved by...

Panel to Discuss Baxter’s HyQvia

06/26/2014

Federal Register Notice: FDA’s Blood Products Advisory Committee will meet 7/31, from 8 a.m. to 5 p.m. at the FDA White Oak ...

Info on Medicated Feeds CGMPs Sent to OMB

06/20/2014

Federal Register Notice: FDA’s proposed collection of information, “Current Good Manufacturing Practice Regulations fo...

Info on Minor Species Drugs Sent to OMB

06/20/2014

Federal Register Notice: FDA’s proposed collection of information, “Index of Legally Marketed Unapproved New Animal Dr...

Info on Medicated Articles CGMPs Sent to OMB

06/20/2014

Federal Register Notice: FDA’s proposed collection of information, “Current Good Manufacturing Practice Regulations fo...

Guidance on Gene Therapies, Vectored Vaccines

06/20/2014

Federal Register Notice: FDA is making available a draft document entitled Guidance for Industry: Determining the Need for and Con...

Comments Sought on GLP Regs for Nonclinical Studies

06/12/2014

Review Period Set for AZ’s Vandetanib

06/11/2014

Federal Register Notice: FDA has determined the regulatory review period for AstraZeneca’s Vandetanib is 4,009 days for exte...

Drug Supply Chain Security Guidance

06/11/2014

Federal Register Notice: FDA is making available a draft guidance for industry entitled Drug Supply Chain Security Act Implementat...